Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | -0.180 | ||
| Révision: | $126.32M | $154.30M | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | -0.550 | -0.830 | -0.2800 |
| Révision: | $138.27M | $155.70M | -$18.97M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | -0.330 | -2.180 | -1.8500 |
| Révision: | $149.17M | $164.50M | -$5.57M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | -0.360 | -1.160 | -0.8000 |
| Révision: | $168.52M | $174.50M | -$15.72M |
